                         SEQUENCE LISTING

<110>  Shire Human Genetic Therapies, Inc.
 
<120>  Anti-CCL2 Antibodies For Treatment of Scleroderma

<130>  2006685-0330

<150>  61/650,149
<151>  2012-05-22

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  99
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Lys Val Ser Ala Ala Leu Leu Cys Leu Leu Leu Ile Ala Ala Thr 
1               5                   10                  15      


Phe Ile Pro Gln Gly Leu Ala Gln Pro Asp Ala Ile Asn Ala Pro Val 
            20                  25                  30          


Thr Cys Cys Tyr Asn Phe Thr Asn Arg Lys Ile Ser Val Gln Arg Leu 
        35                  40                  45              


Ala Ser Tyr Arg Arg Ile Thr Ser Ser Lys Cys Pro Lys Glu Ala Val 
    50                  55                  60                  


Ile Phe Lys Thr Ile Val Ala Lys Glu Ile Cys Ala Asp Pro Lys Gln 
65                  70                  75                  80  


Lys Trp Val Gln Asp Ser Met Asp His Leu Asp Lys Gln Thr Gln Thr 
                85                  90                  95      


Pro Lys Thr 
            


